Sphygmose Pharmaceutical Private Limited - Company Profile

It is a pharma private limited company based in Palakkad, Kerala, India, established in 2012.
2012 Palakkad, Kerala, India Active
Last Updated:
Access Report
About Sphygmose Pharmaceutical Private Limited

Sphygmose Pharmaceutical Private Limited, a active private limited company, was established on 02 February 2012 in Palakkad, Kerala, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230KL2012PTC030420. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Jayasankar Unnikrishnan Cheenikuzhi (Director), Praveen Praveen (Director). Past directors included Nellampani Ravi Pisharam, Ajaighosh. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Room No. 10/694(12), 'Classic Tower', Iind Floor, Opp. Central Excise Building, Mettupalay, Am Street, Palakkad, Kerala, 678001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230KL2012PTC030420

  • Registration Number

    030420

  • Incorporation Date

    02 February 2012

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Ernakulam

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 14 Year, 27 Days
  • Last Filing with ROC 31 Mar 2025
Company report

Sphygmose Pharmaceutical Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sphygmose Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sphygmose Pharmaceutical Private Limited?
Current Directors
Name Designation Appointment Date Status
Jayasankar Unnikrishnan Cheenikuzhi Director 02 Feb 2012 Current
Praveen Praveen Director 02 Feb 2012 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Sep 2021 Past
Pramod Abcsdd Managing Director - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sphygmose Pharmaceutical.

Sphygmose Pharmaceutical Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Sphygmose Pharmaceutical revenue growth over time
Sphygmose Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sphygmose Pharmaceutical?

In 2017, Sphygmose Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sphygmose Pharmaceutical?

Unlock and access historical data on people associated with Sphygmose Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sphygmose Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sphygmose Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sphygmose Pharmaceutical
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Sphygmose Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Sphygmose Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam. was completed.

  • Director Appointment

    Progress on Jayasankar Unnikrishnan Cheenikuzhi was appointed as a Director was appointed as a Director on 02 Feb 2012 & has been associated with this company since 14 years 27 days . was documented.

  • Director Appointment

    The activity Praveen Praveen was appointed as a Director was appointed as a Director on 02 Feb 2012 & has been associated with this company since 14 years 27 days . was completed.

  • Company Incorporation

    Progress on Sphygmose Pharmaceutical Private Limited was registered on 02 Feb 2012 with Roc Ernakulam & aged 14 years 27 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sphygmose Pharmaceutical Private Limited?

The CIN of Sphygmose Pharmaceutical Private Limited is U24230KL2012PTC030420.

Where is Sphygmose Pharmaceutical Private Limited headquartered?

Sphygmose Pharmaceutical Private Limited is headquartered at Room No. 10/694(12), 'Classic Tower', Iind Floor, Opp. Central Excise Building, Mettupalay, Am Street, Palakkad, Kerala, 678001.

When was Sphygmose Pharmaceutical Private Limited incorporated?

Sphygmose Pharmaceutical Private Limited was incorporated on 02 February 2012.

Who are the current directors of Sphygmose Pharmaceutical Private Limited?

The current directors of Sphygmose Pharmaceutical Private Limited are

What is the primary industry of Sphygmose Pharmaceutical Private Limited?

The primary industry of Sphygmose Pharmaceutical Private Limited is Trade.

Is Sphygmose Pharmaceutical Private Limited a listed company?

Sphygmose Pharmaceutical Private Limited is unlisted.

What is the capital structure of Sphygmose Pharmaceutical Private Limited?

The authorized capital of Sphygmose Pharmaceutical Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Sphygmose Pharmaceutical Private Limited?

The compliance status of Sphygmose Pharmaceutical Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available